missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ CD65 Monoclonal Antibody (VIM8), PE
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  Invitrogen™ MA544114

Product Code. 17684566

  • € 441.00 / Pack of 100

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

This antibody recognizes human CD65, an asialo-fucoganglioside expressed on the surface of peripheral blood granulocytes (highly) and monocytes (weakly).

This type 2 fucosylated carbohydrate antigen is expressed on the surface of all myeloid cells during development. Moreover, CD65 is expressed highly on granulocytes and weakly on monocytes in peripheral blood. CD65 has been reported to be a ligand for CD62E (E-Selectin). However, the sialylated form of CD65 (designated CD65s) can be used as a marker for acute myeloid leukemia (AML) as its expression increases as CD34 decreases. Finally, CD65 is important for extravascular infiltration of AML cells.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD65
Monoclonal
PE
Fucoganglioside Type 2; Fucoganglioside Type II
THP-1 cell line.
100 Tests
Primary
4°C, store in dark, DO NOT FREEZE!
Liquid
Flow Cytometry
VIM8
PBS with 0.2% BSA and 15mM sodium azide; pH 7.4
Mouse
Size-exclusion chromatography
RUO
Human
Antibody
IgM
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.